Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.06 USD
Change Today 0.00 / 0.00%
Volume 0.0
KLXC On Other Exchanges
As of 8:10 PM 08/6/15 All times are local (Market data is delayed by at least 15 minutes).

kalex corporation (KLXC) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/6/15 - $0.06
52 Week Low
05/5/15 - $0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KALEX CORPORATION (KLXC)

Related News

No related news articles were found.

kalex corporation (KLXC) Related Businessweek News

No Related Businessweek News Found

kalex corporation (KLXC) Details

Kalex Corp. does not have significant operations. The company intends to acquire or merger with an existing operating business. Previously, it was engaged in the real estate business. The company was formerly known as Pennate Corp. and changed its name to Kalex Corp. in January 1996. Kalex Corp. was incorporated in 1984 and is based in Dallas, Texas.

kalex corporation (KLXC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kalex corporation (KLXC) Key Developments

Kalex Corp. Announces Board Changes

Kalex Corp. entered into an acquisition agreement with all the owners of the common stock of LCP Inc. on June 15, 2015 the company's sole board member, Arnold F. Sock, appointed J. Scott Tassan, Edward Vakser, and Scott N. Weinert, as members of the company's Board of Directors. Immediately thereafter, Mr. Sock resigned as a director and officer of the company.

Kalex Corp. Dismisses Labrozzi & Co., PA as Auditors

As previously reported on its Form 8-K filed on March 3, 2014, Kalex Corp. received notice from the U.S. Securities and Exchange Commission informed the company that effective February 13, 2014 the Public Company Accounting Oversight Board revoked the registration of independent auditor Labrozzi & Co., P.A. As a result of the revocation, the company can no longer include the audit reports of Labrozzi & Co., P. A in the company's filings with the SEC. In addition, as a result of the foregoing, the company is required to have its financial statements for the fiscal year ended June 30, 2012 re-audited by a firm that is registered with the PCAOB. As a result of the foregoing the company, with the approval of its board of directors dismissed Labrozzi & Co., PA.

Kalex Mulls Acquisitions

Kalex Corp. intends to acquire La Derma, Inc. and is in the process of negotiating an acquisition of all its common stock. Kalex expects to make it a wholly owned subsidiary of the company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KLXC:US $0.06 USD 0.00

KLXC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KLXC.
View Industry Companies

Industry Analysis


Industry Average

Valuation KLXC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KALEX CORPORATION, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at